ç·ç¶çççã«ãããæ ¢æ§çŒççºçã¡ã«ããºã ã®è§£æ
ïœåºææèŠç°åžžã«ããçŒçèªå°ãšãã¯ãã°ãªã¢ã«ããçŒçèšæ¶ïœ
çºè¡šã®ãã€ã³ã
1.ç·ç¶çççã®ããŠã¹ã¢ãã«ãçšããŠãçŒççºçã®åå ã調ã¹ããšãããäžéšã®çã®åºææ
ãèŠã®é掻åãšãèé«ã®éå±ããé åã«ãã¯ãã°ãªã¢ã®æŽ»æ§åãšéç©ãèŠãããŸããã
2.è³å ã§éå°ã«æŽ»åããŠãããã¥ãŒãã³ãèå æšèã§ããããŠã¹ãéçºããç·ç¶çççã¢ã
ãã«ãæ€èšãããšãããåå°åŒã«æ²¿ã£ãç¥çµåè·¯ãèå æšèããããã®åå°åŒã«æ²¿ã£ãŠãã¯
ããã°ãªã¢ã掻æ§åããŠããããšãæããã«ãªããŸããã
3.ãã¯ãã°ãªã¢ãè¬å€ã§æå¶ãããšãçŒçã¯æå¶ãããŸãããç·ç¶çççã¢ãã«ããŠã¹ã§ã¯
ãç¶ç¶ããçç·åŒµãåºææèŠãã¥ãŒãã³ã®é掻åãä»ããŠãã¯ãã°ãªã¢ãå±æçã«æŽ»æ§å
ããããã¯ãã°ãªã¢æŽ»æ§åã®æç¶ãçŒçã®æ ¢æ§åã«ã€ãªãã£ãŠããããšãåç©ã¬ãã«ã§æã
ããã«ãªããŸããã
èŠæš
ãåœç«å€§åŠæ³äººæ±æµ·åœç«å€§åŠæ©æ§Â åå€å±å€§åŠå€§åŠé¢å»åŠç³»ç 究ç§(ç 究ç§é·ã»æšæ å®)æ©èœçµç¹åŠåéã®æšå±±Â åè³(ãããŸÂ ã²ãã)ææãæ¡ç寿çŸå(ããã ã ãã¿ã)åææãç 究å¡ã®è¥æ康次(ããã€ã ããã)ãšåžžè倧åŠå¥åº·ãããã¥ãŒã¹åŠéšã®å®äºæ£äœä¹(ããã ãŸãã)åææã®ç 究ã°ã«ãŒãã¯ãç·ç¶çççã§èŠãããç°åžžãªçã¿ã®åå ã®ã²ãšã€ãšããŠãéåžžæèã«ã®ãŒããªãåºæ(æ·±éš)æèŠâ»1 ã®æç¶çãªéè奮ããèé«å ã®åå°åŒâ»2 ã«æ²¿ã£ãŠãç¥çµççã«é¢ãããã¯ãã°ãªã¢â»3ã掻æ§åãããããã«ããæ ¢æ§çŒçãçããŠããããšãè³å ã®é掻åç¥çµåè·¯ããã¬ãŒã¹ã§ããããŠã¹ã¢ãã«åç©ãçšããå®éšã§æããã«ããŸããã
ãç·ç¶çççã¯ã身äœã«ççãæå·ãªã©æãããªåå ããªãã®ã«ãæ ¢æ§çãªç°åžžççãé床ã®ç²åŽæãçããåå äžæã®ç æ°ã§ããè¿å¹Žã®ç 究ã§ãåå ã¯è³ãèé«å ã®ççã®å¯èœæ§ã瀺ãããŠããŸãããããããªãè³ãèé«ã«ççãçããã®ãåå ã¯äžæã§ãããçŸåšã§ãå¹æã®ããæ²»çæ³ã¯éçºãããŠããŸãããä»åã®ç 究ææã¯ãã¹ãã¬ã¹çã«ãã£ãŠäžéšã®çç·åŒµãããã¯åºææèŠã®éè奮ãé·æã«ããã¶ããšã«ãããéåžžæèã«ã®ãŒããªãåºææèŠã®éè奮ããã¯ãã°ãªã¢ãä»ããŠçã¿ãåŒãèµ·ããããšã瀺ããŠãããç¥çµé害æ§çŒçãççæ§çŒçãšã¯ç°ãªãæ°ããçã¿çºçã®ã¡ã«ããºã ã瀺ãããã®ã§ãä»åŸç·ç¶çççã®æ£è ããã®çã¿ãåãããæ²»çã®æšçãšããŠãçç·åŒµã®æå¶ãæµ®ãã³äžãã£ãŠããŸããã
èæ¯
ãç·ç¶çççã¯ãé·æã«ããã£ãŠã身äœã®åºãç¯å²ã«çã¿ãæç¶ããŠèµ·ãããŸããçã¿ä»¥å€ã«ãæ¿ããç²åŽæãç¡ç é害ãäžå®ããã€ãèªç¥é害ãªã©å€åœ©ãªçç¶ã䌎ããŸããç æ°ã®åå ã¯ãŸã ããããã£ãŠããŸãããããããã®çç¶ã¯æ©èœæ§èº«äœçå矀(Functional Somatic Syndrome: FSS)ã«å ±éã«èŠããããã®ãå€ããç¹ã«ççæ§è³èé«ç(æ ¢æ§ç²åŽçå矀)(ME/CFS)ã®çç¶ãšé¡äŒŒããŠããŸãã
ãæ¬ç 究ã°ã«ãŒãã¯ä»¥åãME/CFS ã®ã¢ãã«ã©ããã§ãéå°ãªäžè¢ã®çåçž®ã«ããåºææèŠåºæ¿ãèé«ã®åŸè§ã§ãã¯ãã°ãªã¢ã掻æ§åãããããšã瀺ããŸãããããã«ãã¯ãã°ãªã¢ã®æŽ»æ§åãæå¶ããè¬å€(ãããµã€ã¯ãªã³)ãé«è å ã«æäžãããšãããåç©ã®ç°åžžãªçã¿ã¯æå¶ãããããšããããåºææèŠèªå°æ§ã®çŒçããšããæ°ããªçŒççºçã¡ã«ããºã ãå ±åããŸãããä»åãã®ãããªã¡ã«ããºã ã¯Â ME/CFS ã®ä»ã«åæ§ã«Â FSS ã«å«ãŸããç·ç¶çççã§ãå ±éã§ããå¯èœæ§ãæ€èšŒããããã«æ¬ç 究ãè¡ãããŸããã
ç 究ææ
ãæ¬ç 究ã§ã¯ãç·ç¶çççã¢ãã«ããŠã¹ãšããŠç¥ããããç¹°ãè¿ãå¯å·åºæ¿ã¢ãã«ãçšããŸãããæŒã®éã ããäœæž©(7°C)ãšå®€æž©ãçæéã§ç¹°ãè¿ãç°å¢äžã§Â 1 é±éããŠã¹ã飌è²ãããšãé·æéã«ãããæ ¢æ§çãªçŒçãšç²åŽã«ãã掻åäœäžãçããŸãããäžæ¹ããã®ããŠã¹ã®ç®èãçããããã¯è¡æ¶²æ€æ»ãããŠããæå·ãççã瀺ãéºäŒåã®çºçŸã¯å šãèŠãããŸããã§ããããã®çç¶ã¯ãŸãã«ããã«èŠãããç·ç¶çççã®ç æ ã«é¡äŒŒããŠããŸããæ¬ç 究ã°ã«ãŒããéçºãã Atf3:BAC Tg ããŠã¹ã¯ãç¥çµã®é掻åã®ããŒã«ãŒãšãªã ATF3 ãšããéºäŒåã®äžæµã§ããã³ã³ããªã¢ãæšèããèå èçœ(GFP)ãçºçŸããããŠã¹ã§ããç·ç¶çççã¢ãã«ã«é©çšãããšãé掻åãçããŠããç¥çµçŽ°èã®ããã³ã³ããªã¢ã®ã¿ãèå ã§æšèãããŸããããã³ã³ããªã¢ã¯è»žçŽ¢ã®å 端ããæš¹ç¶çªèµ·ã®å 端ãŸã§ãã¥ãŒãã³ã®é ã ã«ååšãããããé掻åãèµ·ããããã¥ãŒãã³ã®å šäœåãæšèã§ããŸããåŸã£ãŠãã®ããŠã¹ã䜿ãããšã«ãããé掻åãèµ·ãããŠããè³å ã®ç¥çµåè·¯ãæµ®ãã³äžããããããšãå¯èœã«ãªããŸãããã®ããŠã¹ã解æãããšããã足å çã®ç玡éããåŸæ ¹ç¥çµç¯å ã®åºææèŠãã¥ãŒãã³ãèé«åŸè§ããèé«åè§ã®éåãã¥ãŒãã³ãããã«ã¯è¶³å çã®ç¥çµçæ¥åéšã«ããããããããåå°åŒã«æ²¿ã£ãç¥çµåè·¯ãèå æšèãããŸãã(å³Â 1)ããŸãããã«æ²¿ã£ãŠãã¯ãã°ãªã¢ã掻æ§åããŠããããšãæããã«ãªããŸããããŸãããã®ãã¯ãã°ãªã¢ã®æŽ»æ§åãæå¶ããããã«ããã¯ãã°ãªã¢ã®åè£å¢æ®ãæå¶ããè¬å€ãçšããŠããã¯ãã°ãªã¢ããã®åå°åŒã«æ²¿ã£ãŠéç©ããªãããã«ãããšãçã¿ãèŠãããªããªããŸããã
å³1 Atf3:BAC Tg ããŠã¹ã§ç·ç¶çççã¢ãã«ãäœæãããšãé掻åãèµ·ããããã¥ãŒãã³
ããã GFP(ç·è²)ã§æšèããããèå æšèã¯èé«ã®åå°åŒã«æ²¿ã£ãŠã¿ããããGFP ã§æšè
ãããããç¥çµç·ç¶(çœæ )ã«æ²¿ã£ãŠãã¯ãã°ãªã¢(èµ€è²)ã掻æ§åãããcc: äžå¿ç®¡ã
ä»åŸã®å±é
ãç·ç¶çççã¢ãã«ããŠã¹ãçšããä»åã®ç 究ã«ãããç·ç¶çççã§ã¯ãç¡æèã®ãã¡ã«çããçç·åŒµãåºææèŠã®é掻åãåŒãèµ·ããããããèé«å ã§ãã¯ãã°ãªã¢ã®æŽ»æ§åãåŒãè¶ãããšãæããã«ãªããŸãã(å³2)ããŸãããã®æŽ»æ§åãããã¯ãã°ãªã¢ãçŒçã®åå ãšãªãããšãæããã«ãªããŸããã
å³2 æ¬ç 究ã§æããã«ãªã£ãç·ç¶çççã¢ãã«ããŠã¹å ã®é掻åç¥çµåè·¯
ãå ã«æ¬ç 究ã°ã«ãŒãã¯ãæ©èœæ§èº«äœçå矀(FSS)ã«å«ãŸãç·ç¶çççã®é¡çžçŸæ£ã§ãã ME/CFS ã®ã¢ãã«ã©ãããçšããå Žåããåæ§ã®åºææèŠã®é掻åèªå°æ§ã®çŒçãçããŠããããšãæããã«ããŠãã(Yasui et al, 2019)â»4ãå šãç°ãªãåºæ¿ãçšããã¢ãã«åç©ã§é¡äŒŒã®çµæãèŠãããããšãããFSS å šè¬ã«å ±éã®çç¶ãšããŠèŠãããæ ¢æ§çŒçã¯åããããªã¡ã«ããºã ã§çããŠããããšã瀺åããŠãããšèããããŸãã
ãããã£ãŠãFFS ã®æ£è ããã«å ±éã«èŠãããæ ¢æ§çŒçãåãããæ²»çã«ã¯ãè³ãèé«ã«ååšãããã¯ãã°ãªã¢ãæšçãšããããšãæå¹ã§ããä»ãäžéšã®çã®éç·åŒµã解é€ãåºææèŠãã¥ãŒãã³ã®é掻åæå¶ãæšçãšããæ°ããªæ²»çæ³ãèããããŸããä»åŸã¯ãä»åã®çµæã®ããã§ã®å®èšŒãšãæ°ããªæ²»çæšçã«å¯Ÿããå¹æçãªæ²»çæ³ã®éçºãæåŸ ãããŸãã
çšèªèª¬æ
(â»1) åºææèŠ
äœæ§æèŠã«ã¯ãæž©çèŠã觊å§èŠãåºææèŠããããŸãããã®ãã¡çãè ±ãé¢ç¯ãªã©ã®äŒžã³ãåŒã£åŒµããæ²ããå ·åãšãã£ãéåžžããŸãæèã«ã®ãŒããªãæèŠãæ·±éšæèŠãããã¯åºææèŠãšãããŸããåºææèŠãã¥ãŒãã³ã¯ãç玡éãšåŒã°ããçã®äŒžã³ãæ€ç¥ããå容åšããŽã«ãžè ±åšå®ãšåŒã°ããè ±ã®åŒµåãæ€ç¥ããå容åšã®æ å ±ãèé«ã«äŒããŸãã
(â»2) åå°åŒ
ããã§ããåå°ãšã¯ãäŸãã°æå³ããã«çããçã®äŒžã³ãæç¥ããŠèé«ã«æ å ±ãéããèé«éåãã¥ãŒãã³ããã姿å¢ã厩ããªãããã«ãã©ã³ã¹ããšãããã®çåçž®ã®åœä»€ãåºãä»çµã¿ã§ããåå°åŒã¯ãäžäœã®è³ã®äœçšãåããã«èé«ã ãã§äœã®ãã©ã³ã¹ãåãããã®æ å ±ãæµããéç(åè·¯)ããããŸãã
(â»3) ãã¯ãã°ãªã¢
è³ãèé«(äžæ¢ç¥çµ)ã«ååšããå ç«æ åœçŽ°èã§ãããã¯ãã°ãªã¢ã¯æ£åžžãªè³ãèé«ã§ã¯çŽ°é·ãçªèµ·ãåãããªããåšå²ã®ç°å¢ã«ç°åžžããªãããç£èŠããŠããŸãããã¥ãŒãã³ã«ç°åžžãçãããšã掻æ§åããŠç¥çµçŽ°èã«ãšã£ãŠã¯æ¯æ§ã®ããççæ§ç©è³ª(ççæ§ãµã€ãã«ã€ã³ãªã©)ããå Žåã«ãã£ãŠã¯ä¿è·å åãç£çããäºé¢æ§ã®ãã现èã§ããåæã«ããã¯ãã°ãªã¢ã¯è³å ã®ç°ç©ãæ»ãã 现èã®æ®éªžã貪é£ãåãé€ããŠããã现èã§ãã
(â»4) åŒçšæç®
Yasui M, ä» ã Hyper-activation of proprioceptors inducesmicroglia-mediated long-lasting pain in a rat model of chronic fatiguesyndrome, J Neuroinflammation, 16(1):67 (2019), DOI: 10.1186/s12974-019-1456-x.